Literature DB >> 2962584

Augmented synthesis of beta-human atrial natriuretic polypeptide in human failing hearts.

A Sugawara1, K Nakao, N Morii, T Yamada, H Itoh, S Shiono, Y Saito, M Mukoyama, H Arai, K Nishimura.   

Abstract

To elucidate the synthesis of atrial natriuretic polypeptide (ANP) in the failing heart, eighteen human right auricles obtained at cardiovascular surgery were studied. The concentration of alpha-human ANP-like immunoreactivity (alpha-hANP-LI) in human right auricles ranged from 13.8 to 593.5 micrograms/g, and the tissue alpha-hANP-LI concentration in severe congestive heart failure (CHF) (New York Heart Association (NYHA) functional class III or IV) was much higher than those in mild CHF of NYHA class I and class II. The alpha-hANP-LI in the human auricle consisted of 3 major components of ANP, gamma-human ANP (gamma-hANP), beta-human ANP (beta-hANP) and alpha-human ANP (alpha-hANP). The predominant component of alpha-hANP-LI was gamma-hANP in the mild CHF, whereas beta-hANP and/or alpha-hANP were prevailing in the severe CHF and, especially, beta-hANP was markedly increased in human failing hearts.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2962584     DOI: 10.1016/0006-291x(88)90486-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Effects of a small bolus dose of ANF in healthy volunteers and in patients with volume retaining disorders.

Authors:  J M Heim; K Gottmann; J Weil; H Schiffl; F Lauster; K Loeschke; R Gerzer
Journal:  Klin Wochenschr       Date:  1990-07-17

2.  Changes of molecular forms of atrial natriuretic peptide after treatment for congestive heart failure.

Authors:  F Marumo; T Kurosawa; S Takeda; Y Katoh; N Hasegawa; K Ando
Journal:  Klin Wochenschr       Date:  1988-08-01

3.  Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failure.

Authors:  Lia Millucci; Eugenio Paccagnini; Lorenzo Ghezzi; Giulia Bernardini; Daniela Braconi; Marcella Laschi; Marco Consumi; Adriano Spreafico; Piero Tanganelli; Pietro Lupetti; Agnese Magnani; Annalisa Santucci
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.